Skip to content

RoosterBio Logo

Site Navigation

  • Our Technology
    • Foundation for Multiple Therapeutics
    • Powerful Technology
    • Built-In Manufacturing Process
  • Products
    • Human Mesenchymal Stem/Stromal Cells
      • Serum
      • Xeno-free
      • cGMP CliniControl™
    • Cell Culture Media & Supplements
      • Serum
      • Xeno-free
      • cGMP CliniControl™
    • Exosomes/Extracellular Vesicles
      • Media & Supplements
      • cGMP CliniControl™ Production Media
    • Genetic Engineering Tools
      • Genetic Engineering Media
    • Cell & Media Kits
      • hMSC Starter Kits
      • hMSC Donor Screening Kits
      • Bioreactor Kits & Bundles
    • cGMP CliniControl™ Products
      • Human Mesenchymal Stem/Stromal Cells
      • Cell Culture Media & Supplements
      • Exosome/Extracellular Vesicle Production Media
  • Services
    • Process Development Services
    • hMSC Analytical Services
  • Knowledge Center
    • Resources
    • Blog Articles
    • Publications
    • Videos & Webinars
  • About Us
    • Why RoosterBio?
    • Our Leadership
    • Our Collaborators
    • Our Culture
    • Careers
    • FAQs
  • News & Events
    • News
    • Events
    • Press Releases
    • Media Kit
  • Contact Us

Publications

Mesenchymal Stem Cell-Conditioned Media Regulate Steroidogenesis & Inhibit Androgen Secretion in a PCOS Cell Model via BMP-2
October 2021 Cell Therapy, Clinical, Genetic, Immunomodulation

Mesenchymal Stem Cell-Conditioned Media Regulate Steroidogenesis & Inhibit Androgen Secretion in a PCOS Cell Model via BMP-2

SENTI-101, a Preparation of Mesenchymal Stromal Cells Engineered to Express IL12 & IL21, Induces Localized & Durable Antitumor Immunity in Preclinical Models of Peritoneal Solid Tumors
September 2021 Cancer, Cell Therapy, Clinical, Immunomodulation

SENTI-101, a Preparation of Mesenchymal Stromal Cells Engineered to Express IL12 & IL21, Induces Localized & Durable Antitumor Immunity in Preclinical Models of Peritoneal Solid Tumors

Functional Heterogeneity of IFN-Gamma-Licensed Mesenchymal Stromal Cell Immunosuppressive Capacity on Biomaterials
August 2021 Cell Therapy, Clinical, Immunomodulation, MedTech, Devices, & Materials

Functional Heterogeneity of IFN-Gamma-Licensed Mesenchymal Stromal Cell Immunosuppressive Capacity on Biomaterials

Protective Effects of a Hyaluronan-Binding Peptide (P15-1) on Mesenchymal Stem Cells in an Inflammatory Environment
June 2021 Cell Therapy, Immunomodulation

Protective Effects of a Hyaluronan-Binding Peptide (P15-1) on Mesenchymal Stem Cells in an Inflammatory Environment

Characterizing Human Mesenchymal Stromal Cells Immune Modulatory Potency Using Targeted Lipidomic Profiling of Sphingolipids
June 2021 Drug Screening, Immunomodulation

Characterizing Human Mesenchymal Stromal Cells Immune Modulatory Potency Using Targeted Lipidomic Profiling of Sphingolipids

Minimal Effects of Intravenous Administration of Xenogeneic Adipose Derived Stem Cells on Organ Function in a Porcine 40% TBSA Burn Model
June 2021 Cell Therapy, Immunomodulation, Tissue & Organ Engineering

Minimal Effects of Intravenous Administration of Xenogeneic Adipose Derived Stem Cells on Organ Function in a Porcine 40% TBSA Burn Model

Interactions of Human Mesenchymal Stromal Cells with Peripheral Blood Mononuclear Cells in a Mitogenic Proliferation Assay
February 2021 Blood, EVs & MSC Secretome, Immunomodulation

Interactions of Human Mesenchymal Stromal Cells with Peripheral Blood Mononuclear Cells in a Mitogenic Proliferation Assay

Hollow-Fiber Bioreactor Production of Extracellular Vesicles from Human Bone Marrow Mesenchymal Stromal Cells Yields Nanovesicles That Mirrors the Immuno-Modulatory Antigenic Signature of the Producer Cell
February 2021 Bioprocess Tool Development, EVs & MSC Secretome, Immunomodulation

Hollow-Fiber Bioreactor Production of Extracellular Vesicles from Human Bone Marrow Mesenchymal Stromal Cells Yields Nanovesicles That Mirrors the Immuno-Modulatory Antigenic Signature of the Producer Cell

Methods for the Assembly & Characterization of Polyelectrolyte Multilayers as Microenvironments to Modulate Human Mesenchymal Stromal Cell Response
November 2020 Immunomodulation, MedTech, Devices, & Materials

Methods for the Assembly & Characterization of Polyelectrolyte Multilayers as Microenvironments to Modulate Human Mesenchymal Stromal Cell Response

Transcriptome Profiles Acquired during Cell Expansion & Licensing Validate Mesenchymal Stromal Cell Lineage Genes
August 2020 Bioprocess Tool Development, Cell Therapy, Genetic, Immunomodulation

Transcriptome Profiles Acquired during Cell Expansion & Licensing Validate Mesenchymal Stromal Cell Lineage Genes

1 2 Next

Sidebar Navigation

  • Bioprinting
  • Bioprocess Tool Development
  • Blood
  • Cancer
  • Cardiovascular
  • Cell Therapy
  • Clinical
  • Dermal and Wound
  • Diabetes
  • Drug Screening
  • EVs & MSC Secretome
  • Gene Editing
  • Genetic
  • Immunomodulation
  • Lung
  • MedTech, Devices, & Materials
  • Orthopedic
  • Pain
  • Pulmonary
  • Renal
  • Tech Segment
  • Therapeutic Indication
  • Tissue & Organ Engineering

Contact Information

RoosterBio, Inc.
5295 Westview Drive, Suite 275
Frederick, MD 21703
Customer Service: +1 240-831-4914
Headquarters: +1 301-200-5366
Email: info@roosterbio.com

Share

  • Twitter
  • Facebook
  • YouTube
  • LinkedIn

Footer Navigation

  • Our Technology
  • Services
  • About Us
  • News & Events
  • Contact Us
  • Login
  • Products
    • Human Mesenchymal Stem/Stromal Cells
    • Cell Culture Media & Supplements
    • Exosomes/Extracellular Vesicles
    • Genetic Engineering Tools
    • Cell & Media Kits
    • cGMP CliniControl™ Products
  • Knowledge Center
    • Resources
    • Blog Articles
    • Publications
    • Videos & Webinars

Copyright © 2022 RoosterBio, Inc. All Rights Reserved / Privacy Policy / Website design by Wood Street, Inc.

  • Share on Facebook
  • Tweet
  • Share on LinkedIn
  • Email